222 related articles for article (PubMed ID: 35327982)
21. Gene and microRNA Signatures Are Associated with the Development and Survival of Glioblastoma Patients.
Yang Q; Wang R; Wei B; Peng C; Wang L; Hu G; Kong D; Du C
DNA Cell Biol; 2019 Jul; 38(7):688-699. PubMed ID: 31188028
[TBL] [Abstract][Full Text] [Related]
22. Four specific biomarkers associated with the progression of glioblastoma multiforme in older adults identified using weighted gene co-expression network analysis.
Yang Y; Chu L; Zeng Z; Xu S; Yang H; Zhang X; Jia J; Long N; Hu Y; Liu J
Bioengineered; 2021 Dec; 12(1):6643-6654. PubMed ID: 34516348
[TBL] [Abstract][Full Text] [Related]
23. Screening the Significant Hub Genes by Comparing Tumor Cells, Normoxic and Hypoxic Glioblastoma Stem-like Cell Lines Using Co-Expression Analysis in Glioblastoma.
Güven E; Afzal M; Kazmi I
Genes (Basel); 2022 Mar; 13(3):. PubMed ID: 35328072
[TBL] [Abstract][Full Text] [Related]
24. Bioinformatic analysis of the potential molecular mechanism of PAK7 expression in glioblastoma.
Wang X; Liu S; Shao Z; Zhang P
Mol Med Rep; 2020 Aug; 22(2):1362-1372. PubMed ID: 32626960
[TBL] [Abstract][Full Text] [Related]
25. Hub biomarkers for the diagnosis and treatment of glioblastoma based on microarray technology.
Cui K; Chen JH; Zou YF; Zhang SY; Wu B; Jing K; Li LW; Xia L; Sun C; Dong YL
Technol Cancer Res Treat; 2021; 20():1533033821990368. PubMed ID: 34018447
[TBL] [Abstract][Full Text] [Related]
26. Computational analysis and verification of molecular genetic targets for glioblastoma.
Xue L; Liu H; Chen Y; Wei L; Hong J
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32469390
[TBL] [Abstract][Full Text] [Related]
27. Effect of intra- and inter-tumoral heterogeneity on molecular characteristics of primary IDH-wild type glioblastoma revealed by single-cell analysis.
Xiong Z; Yang Q; Li X
CNS Neurosci Ther; 2020 Sep; 26(9):981-989. PubMed ID: 32488994
[TBL] [Abstract][Full Text] [Related]
28. Construction of co-expression modules related to survival by WGCNA and identification of potential prognostic biomarkers in glioblastoma.
Zhou J; Guo H; Liu L; Hao S; Guo Z; Zhang F; Gao Y; Wang Z; Zhang W
J Cell Mol Med; 2021 Feb; 25(3):1633-1644. PubMed ID: 33449451
[TBL] [Abstract][Full Text] [Related]
29. High Expression of Fibronectin 1 Predicts a Poor Prognosis in Glioblastoma.
Wu S; Liu C; Wei X; Nong WX; Lin LN; Li F; Xie XX; Liao XS; Luo B; Zhang QM; Xiao SW
Curr Med Sci; 2022 Oct; 42(5):1055-1065. PubMed ID: 36260267
[TBL] [Abstract][Full Text] [Related]
30. Comprehensive Analysis of CD163 as a Prognostic Biomarker and Associated with Immune Infiltration in Glioblastoma Multiforme.
Li H; Wang D; Yi B; Cai H; Xi Z; Lou X; Li Z
Biomed Res Int; 2021; 2021():8357585. PubMed ID: 34395626
[TBL] [Abstract][Full Text] [Related]
31. PI3K Pathway Inhibition with NVP-BEZ235 Hinders Glycolytic Metabolism in Glioblastoma Multiforme Cells.
Udawant S; Litif C; Lopez A; Gunn B; Schuenzel E; Keniry M
Cells; 2021 Nov; 10(11):. PubMed ID: 34831287
[TBL] [Abstract][Full Text] [Related]
32. Bioinformatics and machine learning methodologies to identify the effects of central nervous system disorders on glioblastoma progression.
Rahman MH; Rana HK; Peng S; Hu X; Chen C; Quinn JMW; Moni MA
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33406529
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive prognostic signature for glioblastoma patients based on transcriptomics and single cell sequencing.
Fan F; Zhang H; Dai Z; Zhang Y; Xia Z; Cao H; Yang K; Hu S; Guo Y; Ding F; Cheng Q; Zhang N
Cell Oncol (Dordr); 2021 Aug; 44(4):917-935. PubMed ID: 34142341
[TBL] [Abstract][Full Text] [Related]
34. Quiescent stem cell marker genes in glioma gene networks are sufficient to distinguish between normal and glioblastoma (GBM) samples.
Mukherjee S
Sci Rep; 2020 Jul; 10(1):10937. PubMed ID: 32616845
[TBL] [Abstract][Full Text] [Related]
35. Non-negative matrix factorization and differential expression analyses identify hub genes linked to progression and prognosis of glioblastoma multiforme.
Akçay S; Güven E; Afzal M; Kazmi I
Gene; 2022 May; 824():146395. PubMed ID: 35283227
[TBL] [Abstract][Full Text] [Related]
36. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
37. Glioblastoma Multiforme: Fewer Tumor Copy Number Segments of the
Lehrer S; Rheinstein PH; Rosenzweig KE
Cancer Genomics Proteomics; 2018; 15(4):273-278. PubMed ID: 29976632
[TBL] [Abstract][Full Text] [Related]
38. Identification of Hub Genes and Key Pathways Associated with Anti-
Arya KR; Bharath Chand RP; Abhinand CS; Nair AS; Oommen OV; Sudhakaran PR
Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33803224
[TBL] [Abstract][Full Text] [Related]
39. Bioinformatics analysis of high-throughput data to validate potential novel biomarkers and small molecule drugs for glioblastoma multiforme.
Qi F; Li Q; Lu X; Chen Z
J Int Med Res; 2020 Jul; 48(7):300060520924541. PubMed ID: 32634050
[TBL] [Abstract][Full Text] [Related]
40. Distinct genomic profile and specific targeted drug responses in adult cerebellar glioblastoma.
Cho HJ; Zhao J; Jung SW; Ladewig E; Kong DS; Suh YL; Lee Y; Kim D; Ahn SH; Bordyuh M; Kang HJ; Sa JK; Seo YJ; Kim ST; Lim DH; Dho YS; Lee JI; Seol HJ; Choi JW; Park WY; Park CK; Rabadan R; Nam DH
Neuro Oncol; 2019 Jan; 21(1):47-58. PubMed ID: 30085274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]